Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isoproterenol infusion to reduce severe spontaneous echo contrast and rule out left atrial appendage thrombus in atrial fibrillation
jRCTs031200261Completed
- Sponsor
- Japan Society for the Promotion of Science
- Start
- Feb 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of isoprenaline in Atrial fibrillation (AFib), sponsored by Japan Society for the Promotion of Science. Started Feb 2021; status: completed.
02
Drugs
isoprenaline
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on jRCTs031200261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031200261.